Torrent Pharmaceuticals Limited
TORNTPHARM
株式のランク
#1213
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
株価
$49.60
時価総額
$18.86B
変化（1日）
-1.42%
変化（1年）
21.57%
国
IN
取引 Torrent Pharmaceuticals Limited (TORNTPHARM)
カテゴリー
Healthcare
Torrent Pharmaceuticals Limited（TORNTPHARM）の発行済株式数
June 2026 時点の発行済株式数 338.45M
Torrent Pharmaceuticals Limited の最新の財務報告および株価によると、現在の発行済株式数は 338.45M です。March 2024 の終わりには、同社は 338.45M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Torrent Pharmaceuticals Limited（TORNTPHARM）の発行済株式数の履歴（2005 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 338.45M | 0.01% |
| 2025 | 338.41M | -0.01% |
| 2024 | 338.45M | 0.00% |
| 2023 | 338.45M | 0.00% |
| 2022 | 338.45M | 0.00% |
| 2021 | 338.45M | 0.00% |
| 2020 | 338.45M | 0.00% |
| 2019 | 338.45M | 0.00% |
| 2018 | 338.45M | 0.00% |
| 2017 | 338.45M | 0.00% |
| 2016 | 338.45M | 0.00% |
| 2015 | 338.45M | 0.00% |
| 2014 | 338.45M | 0.00% |
| 2013 | 338.45M | 0.00% |
| 2012 | 338.45M | 0.00% |
| 2011 | 338.44M | 0.00% |
| 2010 | 338.44M | 0.00% |
| 2009 | 338.44M | 0.00% |
| 2008 | 338.44M | 0.00% |
| 2007 | 338.44M | 0.00% |
| 2006 | 338.44M | 0.00% |
| 2005 | 338.44M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 608.93% |
IN
|
